Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033

The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is valued at US$15.6 billion in 2023 and is projected to grow at a CAGR of 7.4% during the forecast period 2023-2033.

Visiongain Publishes Orphan Drugs Market Report 2023-2033

The global Orphan Drugs market is valued at US$187.6 billion in 2022 and is projected to grow at a CAGR of 11.1% during the forecast period 2023-2033.

Visiongain Publishes 3D Cell Culture and 3D Bioprinting Market Report 2023-2033

The global 3D Cell Culture and 3D Bioprinting market is valued at US$2,277.2 million in 2023 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.

Visiongain Publishes Bioreactors Market Report 2023-2033

The global Bioreactors market was estimated to be valued at US$9,977.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

Visiongain Publishes Immuno-Oncology Clinical Trials Market Report 2023-2033

Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.

Visiongain Publishes In Silico Clinical Trials Market Report 2023-2033

The global In Silico Clinical Trials market is valued at US$3,078.0 million in 2023 and is projected to grow at a CAGR of 8% during the forecast period 2023-2033.

Visiongain Publishes Bionic Devices Market Report 2023-2033

The global Bionic Devices market was valued at US$19.5 billion in 2022 and is projected to grow at a CAGR of 9.5% during the forecast period 2023-2033.

Visiongain Publishes Cancer Vaccines Market Report 2023-2033

The global Cancer Vaccines market is valued at US$8,069.5 million in 2023 and is projected to grow at a CAGR of 14% during the forecast period 2023-2033.

Visiongain Publishes Clinical Trials Support Services Market Report 2023-2033

The global Clinical Trials Support Services market is valued at US$21.9 billion in 2023 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.

Visiongain Publishes Ophthalmic Devices Market Report 2023-2033

The global Ophthalmic Devices market is projected to grow at a CAGR of 4.6% by 2033

Visiongain Publishes Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033

The global Ophthalmic Drugs Contract Manufacturing market was valued at US$3,860.1 million in 2023 and is projected to grow at a CAGR of 6.4% during the forecast period 2023-2033.

Visiongain Publishes Active Pharmaceutical Ingredients (APIs) Market Report 2023-2033

Active Pharmaceutical Ingredients (APIs) market was valued at US$ 222 billion in 2022 and is projected to grow at a CAGR of 6.7% during the forecast period 2023-2033.

Visiongain Publishes NASH Treatment & Therapeutics Market Report 2023-2033

The global NASH Treatment & Therapeutics market is valued at US$4,657.7 million in 2023 and is projected to grow at a CAGR of 38.6% during the forecast period 2023-2033.

Visiongain Publishes Next Generation Sequencing Market Report 2023-2033

The global Next Generation Sequencing market is valued at US$10,626.1 million in 2023 and is projected to grow at a CAGR of 21.1% during the forecast period 2023-2033.

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2023-2033

The global Healthcare Cold Chain Logistics market is valued US$17.8 billion in 2023 and is projected to grow at a CAGR of 9.0% during the forecast period 2023-2033.

Clients & Partners

Deloitte logo
BAE systems logo
DUPONT logo
3M logo
BP logo
Daimler logo
Kelloggs logo
Honeywell logo
Lockhead Martin logo
Raytheon logo
Pfizer logo
TEVA logo
BAYER logo
THALES logo
Unilever logo